| Literature DB >> 27103919 |
Avraham Weiss1, Yichayaou Beloosesky1, Alon Grossman2, Agata Shlesinger1, Nira Koren-Morag3, Ehud Grossman4.
Abstract
BACKGROUND: Little is known about the prevalence of orthostatic hypertension (OHT) and its effect on long-term mortality in the elderly. We evaluated the prevalence of OHT and its effect on mortality in hospitalized elderly patients.Entities:
Keywords: Hypertension; Mortality; Orthostatic; The elderly
Year: 2016 PMID: 27103919 PMCID: PMC4826894 DOI: 10.11909/j.issn.1671-5411.2016.03.004
Source DB: PubMed Journal: J Geriatr Cardiol ISSN: 1671-5411 Impact factor: 3.327
Patients' characteristics.
| Orthostatic hypertension | ||||
| Total | No | Yes | ||
| Males | 229 (48%) | 43 (64%) | 186 (46%) | 0.005 |
| Age, yrs | 81.5 ± 6.8 | 81 ± 6.1 | 82 ± 6.9 | 0.652 |
| Body mass index, kg/m2 | 25.2 ± 4.5 | 24 ± 3.6 | 25.5 ± 4.5 | 0.002 |
| Smokers | 75 (16%) | 20 (32%) | 55 (14%) | < 0.001 |
| Hypertension | 298 (63%) | 39 (58%) | 259 (64%) | 0.367 |
| Diabetes mellitus | 140 (29.5%) | 23 (34%) | 117 (29%) | 0.353 |
| Hyperlipidemia | 178 (40%) | 22 (35.5%) | 156 (41%) | 0.398 |
| Chronic renal failure | 116 (24.5%) | 21 (31%) | 95 (23%) | 0.158 |
| Chronic heart failure | 147 (31%) | 12 (18%) | 135 (33%) | 0.012 |
| Ischemic heart disease | 268 (57%) | 42 (63%) | 226 (56%) | 0.302 |
| Stroke | 152 (32%) | 25 (37%) | 127 (31%) | 0.334 |
| Parkinson's disease | 61 (13%) | 14 (21%) | 47 (12%) | 0.036 |
| Plasma glucose, mg/dL | 121 ± 47 | 126 ± 43 | 120 ± 48 | 0.357 |
| eGFR, mL/min | 56.2 ± 17.7 | 53 ± 17 | 57 ± 18 | 0.150 |
| Medications | ||||
| Diuretics | 163(34%) | 18 (27%) | 145 (36%) | 0.162 |
| ACEI/ARB | 149 (31%) | 21 (31.3%) | 128 (31.4%) | 0.986 |
| β-blockers | 85 (18.4%) | 12 (18%) | 73 (18%) | 0.996 |
| Calcium antagonists | 143 (30%) | 17 (25.4%) | 126 (31%) | 0.356 |
Data are presented as mean ± SD or n (%). ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; eGFR: estimated glomerular filtration rate.
Risk of mortality by clinical and laboratory parameters and orthostatic hypertension.
| Adjusted age, HR (95% CI) | #Adjusted multivariate, HR (95% CI) | |
| Female gender | 0.62 (0.51–0.75) | 0.69 (0.56-0.86) |
| High body mass index* | 0.95 (0.93–0.97) | 0.95 (0.93–0.97) |
| Diabetes mellitus | 1.35 (1.08–1.67) | 1.29 (1.03–1.61) |
| Chronic renal failure | 1.93 (1.55–2.40) | 1.54 (1.21–1.95) |
| Congestive heart failure | 1.56 (1.26–1.91) | 1.41 (1.09–1.81) |
| Ischemic heart disease | 1.40 (1.14–1.71) | 1.25 (1.01–1.55) |
| Atrial fibrillation | 1.35 (1.07–1.71) | 1.20 (0.92–1.57) |
| Stroke | 1.23 (1.00-1.51) | 0.98 (0.79–1.22) |
| Chronic obstructive pulmonary disease | 1.27 (1.01–1.59) | 1.20 (0.95–1.52) |
| Parkinson's disease | 1.51 (1.14–1.99) | 1.06 (0.79–1.42) |
| Dementia | 1.97 (1.57–2.49) | 1.91 (1.50–2.45) |
| Orthostatic hypertension | 0.67 (0.51–0.87) | 0.73 (0.55–0.97) |
*Per 1 kg/m2; #Adjusted for age, gender, body mass index stroke, atrial fibrillation, ischemic heart disease, congestive heart failure, chronic renal failure, diabetes mellitus, Parkinson's disease and dementia.
Figure 1.Survival curves in patients with and without OHT.
Survival curves by OHT adjusted for age, gender, body mass index, stroke, atrial fibrillation, ischemic heart disease, congestive heart failure, chronic renal failure, diabetes mellitus, Parkinson's disease and dementia (P = 0.041). OHT: orthostatic hypertension.